Atlas Trials

DEWI: Watch-and-Wait With Dostarlimab in Localized dMMR/MSI-H Gastric/GEJ Adenocarcinoma Phase II Study

Clinical trial NCT06059495 · RECRUITING

Trial details

NCT number
NCT06059495
Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma - GEJGastric Adenocarcinoma
Start date
2024-01-22
Primary completion
2028-09-01
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.